Lifecome Biochemistry Co Ltd Financial Flexibility Index
Lifecome Biochemistry Co Ltd financial flexibility index. Lifecome Biochemistry Co Ltd (002868) has a Financial Flexibility Index of -0.02x as of December 2025. Free cash flow of CN¥-17.06 Million (operating CF CN¥-112.57 Million minus capex CN¥95.51 Million) represents 0% of total liabilities (CN¥683.78 Million). See Lifecome Biochemistry Co Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Lifecome Biochemistry Co Ltd (2012–2025)
Financial flexibility index of Lifecome Biochemistry Co Ltd from 2012 to 2025. Historical Financial Flexibility Index trend for Lifecome Biochemistry Co Ltd across 14 annual periods. Check cash flow quality index of Lifecome Biochemistry Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Lifecome Biochemistry Co Ltd Financial Flexibility Index by Year (2012–2025)
Lifecome Biochemistry Co Ltd financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Lifecome Biochemistry Co Ltd. For the full cash flow conversion analysis, see 002868 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | CN¥104.72 Million | CN¥-25.08 Million | CN¥683.78 Million | ▼ -12.9% |
| 2024 | 0.18x | CN¥266.46 Million | CN¥141.41 Million | CN¥1.52 Billion | ▼ -1.9% |
| 2023 | 0.18x | CN¥277.78 Million | CN¥-186.76 Million | CN¥1.55 Billion | ▼ -10.7% |
| 2022 | 0.20x | CN¥128.49 Million | CN¥-8.83 Million | CN¥640.56 Million | ▼ -72.6% |
| 2021 | 0.73x | CN¥392.34 Million | CN¥35.17 Million | CN¥536.38 Million | ▼ -57.0% |
| 2020 | 1.70x | CN¥344.51 Million | CN¥90.72 Million | CN¥202.56 Million | ▲ +97.2% |
| 2019 | 0.86x | CN¥199.69 Million | CN¥74.09 Million | CN¥231.55 Million | ▼ -59.7% |
| 2018 | 2.14x | CN¥132.63 Million | CN¥83.70 Million | CN¥62.05 Million | ▲ +12.9% |
| 2017 | 1.89x | CN¥114.67 Million | CN¥96.11 Million | CN¥60.56 Million | ▲ +25.2% |
| 2016 | 1.51x | CN¥150.23 Million | CN¥135.41 Million | CN¥99.32 Million | ▲ +39.3% |
| 2015 | 1.09x | CN¥166.76 Million | CN¥127.11 Million | CN¥153.54 Million | ▲ +147.5% |
| 2014 | 0.44x | CN¥87.42 Million | CN¥62.76 Million | CN¥199.22 Million | ▼ -26.2% |
| 2013 | 0.59x | CN¥134.68 Million | CN¥77.68 Million | CN¥226.45 Million | ▲ +16.0% |
| 2012 | 0.51x | CN¥110.17 Million | CN¥60.92 Million | CN¥214.92 Million | — |